Maiwald
Lawyers at Maiwald and Sterne Kessler analyse how patents with claims directed to medical treatments are handled in the US and in Europe
Sponsored
Sponsored
-
Sponsored by Maiwald Intellectual PropertyIn the first of two articles on the springboard doctrine, Marco Stief of Maiwald explains how the protective effect of a patent can continue to have an impact after the term of protection has ended
-
Sponsored by Maiwald Intellectual PropertyGisela Grabow of Maiwald considers the potential changes to the EU’s general pharmaceutical legislation under a recent proposal, and the main questions raised for stakeholders
-
Sponsored by Maiwald Intellectual PropertyChristian Meyer of Maiwald explains several clarifications under a ruling by the German Federal Court of Justice concerning the cessation of the danger of a repeated infringement
-
Sponsored by Maiwald Intellectual PropertyBo-Hyun Lee of Maiwald considers how the Unified Patent Court will affect the successful German model of having patent attorneys and attorneys-at-law work together to handle the technical aspects of infringement proceedings
-
Sponsored by Maiwald Intellectual PropertyMarco Stief of Maiwald reports on a ruling by the CJEU that significantly extends the liability of online platforms for third-party trademark infringement and explains what it means for online marketplaces and trademark owners
-
Sponsored by Maiwald Intellectual PropertyA shift is required in the finance and banking sectors’ approach to the use of intangible capital assets as collateral, says Marco Stief of Maiwald